Alzheimer'S Drugs

Alzheimer's disease, a progressive neurological disorder, primarily affects memory, thinking skills, and behavior. While there is no cure, several drugs aim to manage symptoms and slow cognitive decline. Cholinesterase inhibitors such as donepezil, rivastigmine, and galantamine are commonly prescribed to enhance communication among brain cells by increasing levels of acetylcholine, a neurotransmitter crucial for memory and learning. Another class of drugs, NMDA receptor antagonists like memantine, regulates glutamate activity to protect brain cells from excess damage, offering symptom relief in moderate to severe Alzheimer's cases. These medications may help maintain quality of life and independence for some individuals, although their effectiveness varies and they do not halt disease progression. Ongoing research seeks more effective treatments and strategies to combat this challenging condition.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jun Hua

Jun Hua

Johns Hopkins University , United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Nazneen N Dewji

Nazneen N Dewji

Cenna Biosciences Inc, United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline London

Jacqueline London

Paris Diderot University, France

Submit your abstract Today

Whatsapp